DTA is convening a broad coalition of stakeholders to advance the industry. Our collective efforts are improving clinical and health economic outcomes through the use of high quality, evidence-based digital therapeutics for patients, clinicians, and payors. We are proud that our cross-industry coalition is comprised of experts regarded as industry thought leaders in healthcare worldwide.
The DTA community is driving the industry forward by developing industry frameworks and resources as well as identifying policy solutions to enable expanded patient and clinician access to high quality, evidence-based digital therapeutics that improve clinical and health economic outcomes.